PPAR
The peroxisome proliferator-activated receptors (PPARs), belonging to the nuclear receptor superfamily, are a group of nuclear receptor proteins that are composed of three isoforms, including PPARγ, PPARα and PPARδ, encoded by separate genes. PPARs have a modular structure characterized by the presence of two highly conserved domains, including the DNA binding domain (DBD) of two zinc fingers and the ligand binding domain (LBD) of 13 α-helices and a small 4-stranded β-sheet. PPARs are ligand-regulated transcription factors controlling gene expression by binding to specific response elements (PPREs) within promoters, where PPARs bind as heterodimers with a retinoid X receptor and interact with cofactors upon binding leading to the increasing of rate of transcription initiation.
- B5581 SR 1664Summary: inhibits Cdk5-mediated PPARγ phosphorylation, antidiabetic agent
- A8957 AUDASummary: Potent epoxide hydrolase inhibitor/PPARα activator
- B6128 Fenofibric acidSummary: ppar inhibitor, lipid-lowering agent
- C3407 GQ-16Summary: partial agonist for PPARγ
- C3544 BMS 687453Summary: PPARα agonist
- C3986 MuraglitazarSummary: dual agonist of PPARα and PPARγ
- C4758 DarglitazoneSummary: PPARγ agonist with antidiabetic actions
- C4916 GW 590735Summary: potent and selective agonist of PPARα
- C4735 N-Octadecyl-N'-propyl-sulfamideSummary: activator of PPARα
- C4892 MCC-555Summary: thiazolidinedione class anti-diabetic compound,a novel PPARα/γ dual ligand